Delivery Order SPE2DB22D2211-SPE2DB24FNHL2
Award Date 4/25/24
Potential Completion Date 4/26/24
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $4,740.41 to AmerisourceBergen Drug Corp for the supply of Lyumjev 100 Unit/mL KwikPen 3mL insulin pens. This competitively awarded, non-set-aside contract carries a firm fixed price and was executed on July 23, 2025, with an ultimate completion date of July 24, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the company's role as a...
- This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of LYUMJEV 200 UNIT/ML KWIKPEN 3ML, a diabetes treatment medication, with a ceiling value of $3,926.76 and a performance period through May 20, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,485.96 firm-fixed-price contract is for the supply of LYUMJEV 100 UNIT/ML KWIKPEN 3ML, a medication used for diabetes management. The contract has a period of performance through March 5, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Insulin Lispro 100 Unit/mL Pen 3mL at a firm fixed price of $1,036.86. The contract has a period of performance through March 12, 2024 and was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,060 to Amerisourcebergen Drug Corporation to supply 100 unit/mL KwikPen 3mL LYUMJEV insulin for treatment of diabetes. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 3, 2023 in support of the Agency's medical readiness and logistics programs. No subcontractors or set aside designations were indicated. The...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LYUMJEV 100 UNIT/ML VIAL 10ML, a diabetes medication. The contract has a firm fixed price of $1,055.53 and an ultimate completion date of July 9, 2025. The contract is not set-aside and is an open competition. AmerisourceBergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Insulin Lispro 100 unit/mL Pen 3mL. The contract has a firm fixed price of $1,529.48 and a completion date of May 16, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a comprehensive range of medical commodities to...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,315.66 firm fixed price delivery order to provide LYUMJEV 100 UNIT/ML KWIKPEN 3ML, a specialty pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support...
- This federal contract award, valued at $3,334.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of LYUMJEV 100 UNIT/ML KWIKPEN 3ML, a specialty medication, and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,953.78 Firm Fixed Price delivery order is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a type of insulin medication. The contract has an ultimate completion date of May 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...